A 68-year-old man presents with progressive fatigue, exertional dyspnea, and epistaxis. Laboratory evaluation reveals hemoglobin 8.6 g/dL, serum IgM paraprotein of 4,200 mg/dL, and bone marrow infiltration by clonal lymphoplasmacytic cells expressing CD19, CD20, and sIgM, lacking CD5 and CD10. Which somatic point mutation is detectable in >90% of patients with Waldenström macroglobulinemia, leading to downstream NF-kB pathway activation through IRAK and BTK?
- ABRAF V600E point mutation
- BMYD88 L265P somatic point mutation
- CJAK2 V617F pseudokinase domain mutation
- DSTAT3 SH2 domain activating mutation